Always new time is money! At least RFK appears to
Post# of 513
Without news there has been no basis in the recent rise in the company pps! Gear up for more increase tomorrow. Many premarket bids may be apparent manana?
UEEC can already check off these. ....
1. Stricter Manufacturing Oversight
A focus on public health and corporate accountability could result in:
More frequent inspections of pharmaceutical and medical device manufacturing facilities.
Enhanced compliance with Good Manufacturing Practices (GMP) and Quality System Regulations (QSR).
Stricter enforcement of supply chain transparency, especially for international suppliers.
Companies should evaluate their quality management systems (QMS) to ensure they meet these potential new requirements.
https://www.prp-us.com/quality-compliance-blog/rfkjr
$5-$10+

